Cargando…

Utility of modified Rankin Scale for brain vascular malformations in hereditary hemorrhagic telangiectasia

BACKGROUND: Approximately 10% of hereditary hemorrhagic telangiectasia (HHT) patients harbour brain vascular malformations (VMs). Intracranial hemorrhage (ICH) from brain VMs can lead to death or morbidity, while treatment options for brain VMs also have associated morbidity. The modified Rankin Sca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thompson, K. P., Nelson, J., Kim, H., Weinsheimer, S. M., Marchuk, D. A., Lawton, M. T., Krings, T., Faughnan, M. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451134/ https://www.ncbi.nlm.nih.gov/pubmed/34538258 http://dx.doi.org/10.1186/s13023-021-02012-y

Ejemplares similares

Predictors of mortality in patients with hereditary hemorrhagic telangiectasia
por: Thompson, K. P., et al.
Publicado: (2021)

Association of common candidate variants with vascular malformations and intracranial hemorrhage in hereditary hemorrhagic telangiectasia
por: Pawlikowska, Ludmila, et al.
Publicado: (2018)

Hereditary Hemorrhagic Telangiectasia with Hepatic Vascular Malformations
por: Nishioka, Yujiro, et al.
Publicado: (2015)

Severity score for hereditary hemorrhagic telangiectasia
por: Latino, Giuseppe A, et al.
Publicado: (2014)

Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia
por: Thompson, K. P., et al.
Publicado: (2022)

Subaortic Membranes in Patients With Hereditary Hemorrhagic Telangiectasia and Liver Vascular Malformations
por: Kim, Agnes S., et al.
Publicado: (2020)

Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations()
por: Girit, Saniye, et al.
Publicado: (2020)

Screening for pulmonary and brain vascular malformations is the North American standard of care for patients with hereditary hemorrhagic telangiectasia (HHT): A survey of HHT Centers of Excellence
por: Kilian, Alexandra, et al.
Publicado: (2020)

CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia
por: Dinakaran, Sajeth, et al.
Publicado: (2023)

Neuropilin-1 deficiency in vascular smooth muscle cells is associated with hereditary hemorrhagic telangiectasia arteriovenous malformations
por: Kilari, Sreenivasulu, et al.
Publicado: (2022)

Hereditary Hemorrhagic Telangiectasia With Liver Vascular Malformation Presenting With High-Output Heart Failure
por: Singh, Gurshawn, et al.
Publicado: (2014)

An analysis of sex differences in pulmonary arteriovenous malformation presentation, complications and management in a large, multinational registry of patients with hereditary haemorrhagic telangiectasia
por: Tuff-Gordon, Eliza, et al.
Publicado: (2023)

Pulmonary Arteriovenous Malformation in a Rare Case of Hereditary Hemorrhagic Telangiectasia
por: Azad, Farhan, et al.
Publicado: (2022)

Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia
por: Crist, Angela M., et al.
Publicado: (2018)

Circulating Angiogenic Cell Dysfunction in Patients with Hereditary Hemorrhagic Telangiectasia
por: Zucco, Liana, et al.
Publicado: (2014)

Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations
por: Wetzel-Strong, Sarah E., et al.
Publicado: (2021)

Localized conditional induction of brain arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia
por: Scherschinski, Lea, et al.
Publicado: (2023)

Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia
por: Faughnan, Marie E., et al.
Publicado: (2018)

Hereditary Hemorrhagic Telangiectasia
por: Kamath, Nagesh, et al.
Publicado: (2015)

Embolotherapy for Pulmonary Arteriovenous Malformations in Patients without Hereditary Hemorrhagic Telangiectasia
por: Shin, Ji Hoon, et al.
Publicado: (2010)

Targeting under-diagnosis in hereditary hemorrhagic telangiectasia: a model approach for rare diseases?
por: Latino, Giuseppe A, et al.
Publicado: (2014)

Pulmonary Arteriovenous Malformation in a Patient with Suspected Hereditary Hemorrhagic Telangiectasia: A Case Report
por: Zuabi, Nadia, et al.
Publicado: (2021)

Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
por: Lee, John M., et al.
Publicado: (2019)

Inter-method reliability of the modified Rankin Scale in patients with subarachnoid hemorrhage
por: Nobels-Janssen, E., et al.
Publicado: (2021)

Pulmonary arteriovenous malformations in children with hereditary hemorrhagic telangiectasia: a longitudinal study
por: Mowers, Katie L., et al.
Publicado: (2018)

Pulmonary gas exchange in hereditary hemorrhagic telangiectasia patients with liver arteriovenous malformations
por: de Picciotto, Carole, et al.
Publicado: (2019)

Hereditary Hemorrhagic Telangiectasia and Arterio-Venous Malformations—From Diagnosis to Therapeutic Challenges
por: Floria, Mariana, et al.
Publicado: (2022)

Therapeutic targeting of vascular malformation in a zebrafish model of hereditary haemorrhagic telangiectasia
por: Snodgrass, Ryan O., et al.
Publicado: (2023)

Novel Brain Arteriovenous Malformation Mouse Models for Type 1 Hereditary Hemorrhagic Telangiectasia
por: Choi, Eun-Jung, et al.
Publicado: (2014)

Sequence variations of ACVRL1 play a critical role in hepatic vascular malformations in hereditary hemorrhagic telangiectasia
por: Giraud, Sophie, et al.
Publicado: (2020)

High output cardiac failure in 3 patients with hereditary hemorrhagic telangiectasia and hepatic vascular malformations, evaluation of treatment
por: Olsen, Lilian B., et al.
Publicado: (2020)

Imaging of Hereditary Hemorrhagic Telangiectasia
por: Carette, Marie-France, et al.
Publicado: (2008)

Hereditary Hemorrhagic Telangiectasia: Diagnosis and Management
por: Angel, Cuesta M.
Publicado: (2022)

Pulmonary Vascular Complications in Hereditary Hemorrhagic Telangiectasia and the Underlying Pathophysiology
por: Bofarid, Sala, et al.
Publicado: (2021)

Thromboembolic hazard in hereditary hemorrhagic telangiectasia
por: Asensi Cantó, Pedro, et al.
Publicado: (2022)

Benefits of Treating Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia: A Retrospective Analysis of 14 Patients
por: Woodall, M. Neil, et al.
Publicado: (2019)

Pulmonary Arteriovenous Malformation and Embolic Myocardial Infarction in a Patient With Hereditary Hemorrhagic Telangiectasia
por: Sánchez-Fernández, Gabriel, et al.
Publicado: (2020)

Predictors of heart failure symptoms in hereditary hemorrhagic telangiectasia patients with hepatic arteriovenous malformations
por: Cusumano, Lucas R., et al.
Publicado: (2021)

Brain arteriovenous malformation in hereditary hemorrhagic telangiectasia: Recent advances in cellular and molecular mechanisms
por: Drapé, Elise, et al.
Publicado: (2022)

Weekly epistaxis duration as an indicator of epistaxis severity in hereditary hemorrhagic telangiectasia—Preliminary results from a randomized controlled trial
por: Wu, Vincent, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5j1k3f1vtden5s53217edh3ump